Super 13 Pro & Prebiotics on the Human Intestinal Microflora

Cheng-Hsin General Hospital

Status

Completed

Conditions

Prebiotics

Probiotics

Treatments

Dietary Supplement: Super 13 Pro & Prebiotics

Study type

Interventional

Funder types

Other

Identifiers

NCT04043000

Super13-2019

Details and patient eligibility

About

This study aim to investigate the roles of the test article in improving gastrointestinal functions and gut microbiota of humans. A total 40 healthy adults were recruited and randomly divided into experimental and control groups, with 20 subjects each, for a 4-week trial. The subjects took the test article, "Super 13 Pro & Prebiotics" or the control article, "The placebo without Super 13 Pro & Prebiotics" during the 4-week drug-intake period. Fecal specimens were collected at the 0th, 2nd, and 4th weeks of the trial for analyzing the bacterial counts of Bifidobacterium spp., Clostridium perfringens, Lactobacillus spp., and Coliform.

Full description

This study aim to investigate the roles of the test article in improving gastrointestinal functions and gut microbiota of humans. A total 40 healthy adults were recruited and randomly divided into experimental and control groups, with 20 subjects each, for a 4-week trial. The subjects took the test article, "Super 13 Pro & Prebiotics" or the control article, "The placebo without Super 13 Pro & Prebiotics" three times a day during the 4-week drug-intake period. Fecal specimens were collected at the 0th, 2nd, and 4th weeks of the trial for analyzing the bacterial counts of Bifidobacterium spp., Clostridium perfringens, Lactobacillus spp., and Coliform.

Enrollment

40 patients

Sex

All

Ages

20 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Healthy adult volunteers and willing to give voluntary written informed consent

Exclusion criteria

Major systemic disease
Pregnancy, parturient and feeding woman, or expect to be pregnant
Abnormal liver function
Abnormal renal function
Abnormal gastrointestinal function
Take medications for gastrointestinal and metabolic diseases
Occurrences of severe diseases within 6 months, such as stroke, myocardial infarction, major trauma and surgery • Poor compliance for study protocol